分割
人工智能
动脉瘤
计算机科学
分辨率(逻辑)
图像分割
放射科
计算机视觉
医学
作者
Tatsat R. Patel,Nikhil Paliwal,Prakhar Jaiswal,Muhammad Waqas,Maxim Mokin,Adnan H. Siddiqui,Hui Meng,Rahul Rai,Vincent M. Tutino
出处
期刊:Medical Imaging 2020: Computer-Aided Diagnosis
日期:2020-03-16
卷期号:: 101-101
被引量:28
摘要
Background: Vascular segmentation of cerebral vascular imaging is tedious and manual, hindering translation of imagebased computational tools for neurovascular disease (such as intracranial aneurysm) management. Current cerebrovascular segmentation techniques use classic model-based algorithms, but such algorithms are incapable of distinguishing vasculature from artifacts. Deep Learning, specifically the widely accepted U-Net architecture, could be an effective alternative to conventional approaches for cerebrovascular segmentation, but has been shown to perform poorly in segmentation of smaller yet critical vessels. Methods: In this study, we present a methodology using a specialized convolutional neural network (CNN) architecture— DeepMedic—which uses multi-resolution inputs to enhance the field of view of the architecture, thereby enhancing the accuracy of segmentation of smaller vessels. To show the capability of this architecture, we collected and segmented a total of 100 digital subtraction angiography (DSA) images of cerebral vessels for training, internal validation, and testing (n=80, n=10, and n=10, respectively). Results: The DeepMedic architecture yielded high performance with a Connectivity-Area-Length (CAL) of 0.84±0.07 and a dice similarity coefficient (DSC) of 0.94±0.02 in the independent testing cohort. This was better than U-Net optimized for the patch-size and %-overlap in predictions, which performed with a CAL of 0.79±0.06 and a DSC of 0.92±0.02. Notably, our work demonstrated that DeepMedic (CAL: 0.45±0.12) outperformed U-Net (CAL: 0.59±0.11) for segmentation of smaller vessels. Conclusions: Our work showed DeepMedic performs better than the current state-of-the-art method for cerebrovascular segmentation. We hope this study begins to bring a high fidelity deep-learning based approach closer to clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI